STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
Public ClinicalTrials.gov record NCT03489629. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the micro-biologic efficacy and safety of a streamlined treatment for early onset methicillin-resistant staphylococcus aureus (MRSA) in patients with cystic fibrosis.
Study identification
- NCT ID
- NCT03489629
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 49 participants
Conditions and interventions
Conditions
Interventions
- Trimethoprim Sulfamethoxazole (TMP/SMX) Drug
- Minocycline Drug
- Mupirocin Drug
- Chlorhexidine Gluconate Drug
- Environmental Decontamination Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 2 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 3, 2018 (Actual)
- Primary completion
- Sep 30, 2025 (Actual)
- Completion
- Jan 31, 2026 (Actual)
- Last update posted
- Sep 15, 2026
2018 – 2026
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Jewish Health | Denver | Colorado | 80206 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| University of Michigan Health System | Ann Arbor | Michigan | 48109 | — |
| St. Louis Children's Hospital | St Louis | Missouri | 63110 | — |
| N.C. Memorial Hospital and N.C. Children's Hospital | Chapel Hill | North Carolina | 27599 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Cook Children's Medical Center | Fort Worth | Texas | 76104 | — |
| Texas Children's Hospital, Baylor College of Medicine | Houston | Texas | 77030 | — |
| University of Washington Medical Center and Seattle Children's | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03489629, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03489629 live on ClinicalTrials.gov.